Abstract:Studies have confirmed that rituximab (RTX) can improve the efficacy of BL, but there is a certain effect on the level of immunoglobulin, which will lead to the verification of infection, and the previous study of our center has confirmed that reducing the dose of RTX (4 doses) can achieve a similar effect to the standard dose of RTX (6 doses), can it reduce the effect on the level of immunoglobulin? To date, few studies have concentrated on the effects of immunoglobulin (Ig) on Chinese paediatric patients. This study aimed to examine whether there is a variation in the impact of different doses of RTX on immunoglobulin levels in the high-risk group of children with BL. Clinical data of high-risk pediatric patients with BL who were treated in Beijing Children's Hospital (Beijing, China) were retrospectively analysed. Baseline characteristics and serum Ig levels were collected at four distinct time points (t0 = pre-chemotherapy, t1 = at the end of chemotherapy, t2 = 6 months post-chemotherapy, t3 = 12 months post-chemotherapy). Ig levels were measured at various time points before and after treatment within three RTX treatment groups: R0 group (standard chemotherapy without RTX), R6 group (6 doses of RTX + chemotherapy), and R4 group (4 doses of RTX + chemotherapy). The objective was to compare whether differences existed among the three groups. The results revealed that the study enrolled 300 high-risk BL patients, including 256 boys and 44 girls, distributed across three groups based on RTX dosage: R0 group ( n = 38), R6 group ( n = 87), and R4 group ( n = 175). Median Ig levels were assessed at four time points (t0, t1, t2, t3) for each group. In the R0 group, IgA and IgM levels significantly decreased at t1 compared with t0 ( P = 0.006 and 0.002, respectively), while were gradually recovered at t2, returning to t0 levels at t3 ( P = 0.073 and 0.293, respectively). IgG levels exhibited no significant difference between t0 and t1 ( P = 0.89), reaching their lowest levels at t2 and returning to t0 levels at t3 ( P = 0.14). In the R4 group, the minimum levels of IgA, IgM, and IgG were identified at t1 ( P < 0.001, < 0.001, and < 0.001, respectively), which were gradually recovered at t2, while remained lower than t0 levels at t3 ( P < 0.001, < 0.001, and = 0.005, respectively). The R6 group exhibited reduction in IgA and IgM levels at t1, with gradual recovery at t2 and t3, while remained lower than t0 levels ( P = 0.003 and < 0.001, respectively). IgG levels in the R6 group decreased at t1 ( P < 0.001) and did not return to t0 levels at t3 ( P = 0.004). In the R4 and R6 groups, it was observed that children with hypogammaglobulinemia pre-RTX were more likely to combine with persistent hypogammaglobulinemia (PH-Ig) post-RTX. A 1:1 matched comparison between R4 and R6 groups (78 patients each) revealed consistently higher IgA, IgM, and IgG levels in the R4 group at each time point after chemotherapy. Notably, IgA and IgG levels recovered earlier in the R4 group than those in the R6 group ( P < 0.05). Burkitt lymphoma in the high-risk group were more likely to complicated hypoimmunoglobulinemia after treatment, it is important to monitor Ig levels before and during treatment, and to inform replacement therapy for Ig. Compared with standard chemotherapy group, the RTX group had a longer time of low Ig and a slower recovery, reducing the dosage of rituximab can improve the recovery of IgA and IgG levels.

[Effect of chaihu guizhi decoction on the immunoglobulin and IgG subgroup in children with recurrent respiratory tract infection]

Changes and significances of cytokines and immunoglobulin in serum in children with hand-foot-mouth disease

Clinical observation of the effect of modified Ginseng-Schisandra decoction (MGSD) on trace elements and immune function in children with spleen deficiency syndrome after recurrent respiratory tract infection (RRTI): a randomized controlled trial

Influence of Bushengubiao Prescription on IFN-γ and IL-4 Protein Content in Culture-supernatant of Th Cells in Patients with RRTI

Curative Effect and Immunologic Effect of Astragalus Essence Oral Liquid on Infantile Repeated Respiratory Infection

Clinical Study of Huanerjin's Effect on Repeated Respiratory Tract Infection in Bronchial Asthma Children

Effects of Lantigen B on Salivary Secretory Immunoglobulin A Level of Children with Recurrent Respiratory Infection

Effects of cefuroxime axetil combined with Xingpi Yanger granules on the serum gastrin, motilin, and somatostatin levels in children with upper respiratory tract infection accompanied by diarrhea: results of a randomized trial

Safety and efficacy of Yupingfeng granules in children with recurrent respiratory tract infection: A randomized clinical trial

Effect of Xuanfei-Liyan patch on immune function in recurrent respiratory tract infection children

Clinical Analysis and Study on Pathogenesis in Children with Hypogammaglobulinemia

[Preventive effects of a sachet of Chinese herbs on influenza and its immune regulation]

Immune Mechanism of Shuanghua Baidu Decoction on Children' S Seasonal Influenza

Curative Effect Observation of Huangqi on Assistant Treatment of Children's Cytomegalovirus

Effects of different doses of rituximab on immunoglobulin levels in high-risk pediatrics with Burkitt's lymphoma

A Study on the Effect of Traditional Chinese medicine Chaihu-guizhi Decoction Reducing the Susceptibility and Severity of Influenza in Depressed Mice

Efficacy of Chaihu Jisang decoction on post-infection cough and its effect on cough reflex sensitivity

The Clinical Significance of Serum Immunoglobulin Level in Children with Severe Pneumonia

Effect observation of cefotaxime sodium combined with xiaochaihu decoction in the treatment of lower respiratory tract infection

Comparison of effect with different drug to children with rotavirus enteritis

The clinical significance of IgG4 in the bronchoalveolar lavage fluid of rheumatic disease related interstitial lung disease